The Rosiglitazone Maleate Tablets, cataloged under National Stock Number 6505-01-474-5604, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. Government technical data includes 1 specification, cited from the U.S. Government catalog. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-474-5604 |
| Item Name | Rosiglitazone Maleate Tablets |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Status | ACTIVE |
| Supplementary Features | USED TO CONTROL TYPE 2 DIABETES MELLITUS |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Reference | Meaning |
|---|---|
| NDC00029-3160-20 | 3/9 Design control — primary reference U.S. Government activity |
| 00-0355 | 5/1 Secondary reference U.S. Government activity |
| AVANDIA | 5/9 Secondary reference U.S. Government activity |
NSN 6505-01-474-5604 is a Rosiglitazone Maleate Tablets, classified under FSC 6505, Drugs and Biologicals. Status: active.
Key specifications for 6505-01-474-5604: Supplementary Features: USED TO CONTROL TYPE 2 DIABETES MELLITUS; Special Features: 8 MG; BOTTLE OF 100 TABLETS; STORE AT 25 DEGREES C (77 DEGREE F); Part Name Assigned by Controlling Agency: ROSIGLITAZONE TABLETS 8MG 100S TO CONTROL TYPE 2 DIABETES MELLITUS. 1 specification is documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.